ABOUT US
We are a multidisciplinary group of experts working closely with customers to deliver tailored solutions across the entire project lifecycle. Our expertise ranges from radiopharmaceutical systems—such as hot cells, dose dispensing and monitoring devices—to integrated turn-key solutions for aseptic filling and containment for pharmaceutical and biotech applications.
Our leadership in isolation technology is built on pioneering experience in shielded isolators for radiopharmaceuticals and has evolved into cutting-edge solutions for processes including ATMP production, aseptic filling of pharmaceutical and biologic products, HPAPI handling, and controlled environment applications.
FEATURED CONTENT
-
Operator technique can cause rapid transfer port integrity checks to vary. Automated verification may improve repeatability, though compatibility with existing equipment determines suitability.
-
Material transfer delays rarely trace to a single piece of equipment. Capacity, decontamination timing, and handling workflow interact, and contamination control shapes where throughput is actually lost.
-
Choosing among passive open, active open, and closed barrier configurations is only the first step. Airflow, equipment geometry, and intervention frequency determine whether a design protects the process.
-
Containment performance alone does not settle isolator selection. Workflow fit, operator ergonomics, transfer and cleaning, and long-term operation each shape whether a system works in practice.
-
EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.
-
Rising Annex 1 demands are pushing facilities to rethink contamination control. See how RABS retrofits offer a practical path to compliance, combining effective containment and faster implementation.
CONTACT INFORMATION
TEMA SINERGIE
Via Malpighi 120
Faenza, 48014
ITALY
Phone: +39-0546-622663